Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,383
datasets available to search
ShareScore release 0.9.0
Dataset results
1,383 results for “HCC”
HCC Tumor
no description
HCC Tumor
no description
Abbreviated MRI Protocol for the Assessment of Ablated Area in HCC Patients
<p>We uploaded the images of the article: Granata V, Grassi R, Fusco R, Setola SV, Belli A, Piccirillo M, Pradella S, Giordano M, Cappabianca S, Brunese L, Grassi R, Petrillo A, Izzo F. Abbreviated MRI Protocol for the Assessment of Ablated Area in HCC Patients. Int J Environ Res Public Health. 2021 Mar 30;18(7):3598. doi: 10.3390/ijerph18073598. PMID: 33808466; PMCID: PMC8037601.</p>
New incidence or recurrence hepatocellular carcinoma (HCC) in genotype 4 hepatitis C virus treated with sofosbuvir/daclatasvir with or without ribavirin
<p><span><b>Background</b>: Several studies have resulted in controversial data about the recurrence or new incidence of hepatocellular carcinoma (HCC) in patients with hepatitis C who were treated with direct-acting antivirals (DAAs). </span></p> <p><span><b>Aim:</b> This observational study aimed to assess the occurrence rate of HCC in patients who developed a sustained virological response (SVR).. </span></p> <p><span><b>Methods</b>: A six-month prospective study was done at the National Hepatology and Tropical Medicine Research Institute [NHTMRI] in Cairo, Egypt on 150 chronic hepatitis C (CHC) patients treated with sofosbuvir and daclatasvir with or without ribavirin. Patients were assigned into two groups according to their laboratory values to either receive sofosbuvir/daclatasvir and ribavirin (S/D/R) or receive only sofosbuvir/daclatasvir (S/D). The main outcome measure was the occurrence of HCC.</span></p> <p><span><b>Results</b>: SVR-12 was 100%. 8.5% of patients developed HCC in the S/D/R group, while 0% in the S/D group.</span></p> <p><span><b>Conclusion:</b> New incidence or recurrence of HCC may occur in CHC genotype 4 cirrhotic patients receiving sofosbuvir/daclatasvir and ribavirin (difficult to treat) although achieving SVR. The cause of HCC development in this study is cirrhosis, not the administered DAAs.</span></p>
Anti-PD-1 Antibody Plus DEB-TACE for BCLC Stage A/B HCC
ClinicalTrials.gov study NCT04174781. IPD Sharing: NO. Countries: 1. Publications: 1.
TACE and Sorafenib for Advanced Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT00618384. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dietary Intervention and Gut Microbiota in Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT07143955. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Predictive Power of Share Wave Fibro Scan in HCC After HCV Infection
ClinicalTrials.gov study NCT05105828. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Randomized Study of Adjuvant Radiotherapy After Curative Resection of HCC With Narrow Margin (RAISE)
ClinicalTrials.gov study NCT03732105. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study)
ClinicalTrials.gov study NCT02311205. IPD Sharing: Not stated. Countries: 1. Publications: 7.
A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT04344158. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV)
ClinicalTrials.gov study NCT04745403. IPD Sharing: NO. Countries: 1. Publications: 3.
Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)
ClinicalTrials.gov study NCT00866957. IPD Sharing: Not stated. Countries: 1. Publications: 32.
A Study of the Combination of Anti-PD-1 AK105 and Anlotinib in First-line Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT04172571. IPD Sharing: NO. Countries: 1. Publications: 2.
Case-Control Study of the Glycotest™ HCC Panel Vs AFP for the Detection of Early-stage Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03878550. IPD Sharing: NO. Countries: 2. Publications: 1.
The Safety and Maximum Tolerated Dose of Axitinib in Combination With Radiotherapy for HCC
ClinicalTrials.gov study NCT02814461. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Pharmacogenetic of Doxorubicin in HCC.
ClinicalTrials.gov study NCT06313047. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Randomized, Controlled Phase III Trial of Sorafenib With or Without cTACE in Patients With Advanced HCC
ClinicalTrials.gov study NCT01829035. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Anlotinib Hydrochloride Combined With Sintilimab Injection in the Treatment of Advanced Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT04052152. IPD Sharing: NO. Countries: 1. Publications: 1.
Comparing Re-TACE Versus SABR for Post-prior-TACE Incompletely Regressed HCC: a Randomized Controlled Trial (TASABR)
ClinicalTrials.gov study NCT02921139. IPD Sharing: UNDECIDED. Countries: 1. Publications: 7.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.